Behradmanesh et al. RC. Homeostasis model assess- ment: insulin resistance and beta- cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9. [3899825] [doi:10.1007/BF00280883] 26 Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A. Charac- terization of groups of hyperandro- genic women with acanthosis nigri- cans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endo- crinol Metab 1987;65:499-507. [330 5551] [doi:10.1210/jcem-65-3-499] 27 Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syn- drome. Diabetes 1989;38:1165-74. [2670645] [doi:10.2337/diabetes.38. 9.1165] 28 Jehn M, Clark JM, Guallar E. Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care 2004;27:2422-8. [1545191] [doi:10.2337/diacare.27.10.2422] 29 Ford ES, Cogswell ME. Diabetes and serum ferritin concentration among U.S. adults. Diabetes Care 1999;22:1978-83. [10587829] [doi: 10.2337/diacare.22.12.1978] 30 Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM. Effect of long- term treatment with metformin add- ed to hypocaloric diet on body com- position, fat distribution, and andro- gen and insulin levels in abdominal- ly obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab 2000;85:2767-74. [10946879] [doi: 10.1210/jc.85.8.2767] 31 Festa A, D'Agostino R Jr, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP, Haffner SM. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 2001; 25:1407-15. [11673759] [doi:10.10 38/sj.ijo.0801792] 32 Pannacciulli N, Cantatore FP, Minenna A, Bellacicco M, Giorgino R, De Pergola G. C-reactive protein 33 34 is independently associated with to- tal body fat, central fat, and insulin resistance in adult women. Int J Obes Relat Metab Disord 2001; 25:1416-20. [11673760] [doi:10 .1038/sj.ijo.0801719] Morin-Papunen LC, Vauhkonen I, Koivunen RM, Ruokonen A, Martikainen HK, Tapanainen JS. En- docrine and metabolic effects of met- formin versus ethinyl estradiol- cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study. J Clin Endocrinol Metab 2000;85:3161-8. [10999803] [doi:10.1210/jc.85.9.3161] Morin-Papunen L, Vauhkonen I, Koivunen R, Ruokonen A, Martikainen H, Tapanainen JS. Met- formin versus ethinyl estradiol- cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study. J Clin Endocrinol Metab 2003; 88:148-56. [12519844] [doi:10.1210/ jc.2002-020997] 492 WWW.ircmj.com Vol 13 July 2011